Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1723757rdf:typepubmed:Citationlld:pubmed
pubmed-article:1723757lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C1522242lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C0003316lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C0022885lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C0014441lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C0025971lld:lifeskim
pubmed-article:1723757lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:1723757pubmed:issue3lld:pubmed
pubmed-article:1723757pubmed:dateCreated1992-3-16lld:pubmed
pubmed-article:1723757pubmed:abstractTextELISA double antibodies additivity test was employed to identify the epitopes which can be recognized by monoclonal antibodies (McAbs) against IgM of a patient with B chronic lymphocytic leukemia (B-CLL). The computer grouping programme analysis showed that 4 anti-isotype McAbs could be divided into two groups and 10 anti-idiotype McAbs could be divided into four groups. The result was consistent with that of the indirect ELISA, ELISA sandwich as well as ELISA inhibition test. The above findings suggested that there are at least 6 distinct IgM epitopes which can specifically react with 14 McAbs. Our study indicated that the combination of the ELISA additivity test and the computer grouping programme analysis provides a helpful tool for researchers into the relationship between the structure and function of antigens.lld:pubmed
pubmed-article:1723757pubmed:languageenglld:pubmed
pubmed-article:1723757pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1723757pubmed:citationSubsetIMlld:pubmed
pubmed-article:1723757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1723757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1723757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1723757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1723757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1723757pubmed:statusMEDLINElld:pubmed
pubmed-article:1723757pubmed:issn0257-716Xlld:pubmed
pubmed-article:1723757pubmed:authorpubmed-author:WangX LXLlld:pubmed
pubmed-article:1723757pubmed:authorpubmed-author:TUMMlld:pubmed
pubmed-article:1723757pubmed:authorpubmed-author:ZhangYYlld:pubmed
pubmed-article:1723757pubmed:authorpubmed-author:ZhuH FHFlld:pubmed
pubmed-article:1723757pubmed:authorpubmed-author:ShenG XGXlld:pubmed
pubmed-article:1723757pubmed:authorpubmed-author:SumEElld:pubmed
pubmed-article:1723757pubmed:authorpubmed-author:AhnK JKJlld:pubmed
pubmed-article:1723757pubmed:issnTypePrintlld:pubmed
pubmed-article:1723757pubmed:volume11lld:pubmed
pubmed-article:1723757pubmed:ownerNLMlld:pubmed
pubmed-article:1723757pubmed:authorsCompleteYlld:pubmed
pubmed-article:1723757pubmed:pagination129-34lld:pubmed
pubmed-article:1723757pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:meshHeadingpubmed-meshheading:1723757-...lld:pubmed
pubmed-article:1723757pubmed:year1991lld:pubmed
pubmed-article:1723757pubmed:articleTitleStudies on monoclonal anti-idiotypic and anti-isotypic antibodies against leukemia and myeloma: III. Analysis of monoclonal antibodies recognizing the antigenic epitopes by use of ELISA additivity test and microcomputer grouping programme.lld:pubmed
pubmed-article:1723757pubmed:affiliationLaboratory of Immunology, Tongji Medical University, Wuhan.lld:pubmed
pubmed-article:1723757pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1723757pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed